Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 17 horas · Sai Life Sciences IPO: Of the IPO proceeds, funds to the tune of Rs 600 crore will be used for debt payment and a portion will be used for corporate general purposes, the draft papers filed on ...

  2. Hace 2 horas · Nepra Foods is on a mission to make healthy, enjoyable food for everybody. ON BEHALF OF THE BOARD OF DIRECTORS. David Wood, Chief Operating Officer and Interim CFO. Investor Relations Toll-free ...

  3. Hace 11 horas · Sai Life Sciences files DRHP for IPO with TPG-backed OFS, aiming to raise ₹800 crore for growth and debt repayment. India World Movies Budget 2024 e-Paper Menu; Visual Story Data

  4. Hace 1 día · However, its high debt and weak long-term fundamentals may be a cause for concern for investors. Evexia Lifecare, a microcap company in the lubricants industry, has recently received a 'Hold' rating from MarketsMOJO on July 15, 2024. This upgrade comes after the company declared positive results in the first quarter of 2024, following two ...

  5. en.wikipedia.org › wiki › Cody_RhodesCody Rhodes - Wikipedia

    Hace 1 día · Cody Garrett Runnels Rhodes (born Cody Garrett Runnels; June 30, 1985) is an American professional wrestler. As of April 2022, he is signed to WWE, where he performs on the SmackDown brand and as of April 2024, he is the current Undisputed WWE Champion, recognized as both the WWE Champion and WWE Universal Champion in his first reign with each.

  6. Hace 17 horas · Sai Life Sciences files IPO papers with Sebi; aims to raise Rs 800-cr via fresh issue Of the IPO proceeds, funds to the tune of Rs 600 crore will be used for debt payment and a portion will be used for corporate general purposes, the draft papers filed on Friday showed.

  7. Hace 15 horas · Of the IPO proceeds, funds to the tune of Rs 600 crore will be used for debt payment and a portion will be used for corporate general purposes, the draft papers filed on Friday showed. ... The Hyderabad-based Sai Life Sciences provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule ...